Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Nanda who wrote (2643)	1/14/1998 5:08:00 PM
From: DD™	Read Replies (1) \| Respond to of 3906

Nanda: Does HVSF have any more "staying power" following today's "rise"? A 300% gain in 2 days seems like too much too soon. HVSF certainly showed some "firmness" into the close. (Sorry, couldn't help it with the puns). DD

To: Nanda who wrote (2643)	1/14/1998 6:01:00 PM
From: Afaq Sarwar	Read Replies (2) \| Respond to of 3906

Nanda, Thanks. And congratulations to you too as well! Question: Why $4 specifically? Any particular reason (technical indicators, etc. or others) or just gut feeling. I believe that they are both equally valid. My hope is that the stock climbs to around $5 or so before HVSF receives approval from FDA to proceed with Phase II. My sense is that all the preparatory work to start Phase II is in place. Also, if stock price gets to around $4 or $5, may be the company can require the debenture holder to covert. That will be a nice little change. In any case I would to stay for the long haul. It will be nice to see this stock achieve the valuation that VVUS has alraedy achieved (not their current valuation). Afaq Sarwar